METASTATIC COLORECTAL CANCER (MCRC)

Clinical trials for METASTATIC COLORECTAL CANCER (MCRC) explained in plain language.

Never miss a new study

Get alerted when new METASTATIC COLORECTAL CANCER (MCRC) trials appear

Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (MCRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 3 Not yet finished but already full! 1 Completed 1

New hope for End-Stage colon cancer patients in major drug trial

Disease control Ongoing

This study is for people with advanced colorectal cancer that has spread and has stopped responding to all standard treatments. It compares two approaches: taking the drug regorafenib alone versus taking regorafenib combined with another drug called irinotecan. The main goal is t…

Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)

Phase: PHASE3 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

METASTATIC COLORECTAL CANCER (MCRC)

Get alerted when new METASTATIC COLORECTAL CANCER (MCRC) trials appear

New hope for End-Stage colon cancer patients in major drug trial